GLS and cancer: Indeed, since many cancer cells express GLS-1 at much higher levels than normal cells do [129], GLS-1 inhibition in cancer cells could increase the glutamine concentration in a tumor microenvironment and human plasma, with the result of stimulating antitumor T lymphocytes and promoting anticancer immunity.